Report Detail

Request for Sample of this report

Pharma & Healthcare Global Intravenous (IV) Ibuprofen Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2806708
    • |
  • 24 January, 2019
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.

Scope of the Report:
The worldwide market for Intravenous (IV) Ibuprofen is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Intravenous (IV) Ibuprofen in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose

Market Segment by Applications, can be divided into
Pain
Fever
Inflammation

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous (IV) Ibuprofen product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous (IV) Ibuprofen, with price, sales, revenue and global market share of Intravenous (IV) Ibuprofen in 2017 and 2018.
Chapter 3, the Intravenous (IV) Ibuprofen competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous (IV) Ibuprofen breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Intravenous (IV) Ibuprofen market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Intravenous (IV) Ibuprofen sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Intravenous (IV) Ibuprofen Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 100 mg Dose
      • 1.2.2 200 mg Dose
      • 1.2.3 400 mg Dose
      • 1.2.4 800 mg Dose
    • 1.3 Market Analysis by Applications
      • 1.3.1 Pain
      • 1.3.2 Fever
      • 1.3.3 Inflammation
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Cumberland Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Alveda Pharmaceuticals
      • 2.2.1 Business Overview
      • 2.2.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 CSL Limited
      • 2.3.1 Business Overview
      • 2.3.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Sandor Medicaids
      • 2.4.1 Business Overview
      • 2.4.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 PT. Soho Industri Pharmasi
      • 2.5.1 Business Overview
      • 2.5.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Germin MED
      • 2.6.1 Business Overview
      • 2.6.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Grifols
      • 2.7.1 Business Overview
      • 2.7.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Gloria Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Al Nabeel International
      • 2.9.1 Business Overview
      • 2.9.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Laboratorios Valmorca
      • 2.10.1 Business Overview
      • 2.10.2 Intravenous (IV) Ibuprofen Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Intravenous (IV) Ibuprofen Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Intravenous (IV) Ibuprofen Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Intravenous (IV) Ibuprofen Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Intravenous (IV) Ibuprofen Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Intravenous (IV) Ibuprofen Market Analysis by Regions

    • 4.1 Global Intravenous (IV) Ibuprofen Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Intravenous (IV) Ibuprofen Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 4.3 Europe Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 4.5 South America Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)

    5 North America Intravenous (IV) Ibuprofen by Country

    • 5.1 North America Intravenous (IV) Ibuprofen Sales, Revenue and Market Share by Country
      • 5.1.1 North America Intravenous (IV) Ibuprofen Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Intravenous (IV) Ibuprofen Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 5.3 Canada Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)

    6 Europe Intravenous (IV) Ibuprofen by Country

    • 6.1 Europe Intravenous (IV) Ibuprofen Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Intravenous (IV) Ibuprofen Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Intravenous (IV) Ibuprofen Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 6.3 UK Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 6.4 France Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 6.5 Russia Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 6.6 Italy Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Intravenous (IV) Ibuprofen by Country

    • 7.1 Asia-Pacific Intravenous (IV) Ibuprofen Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Intravenous (IV) Ibuprofen Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Intravenous (IV) Ibuprofen Revenue and Market Share by Country (2014-2019)
    • 7.2 China Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 7.3 Japan Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 7.4 Korea Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 7.5 India Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)

    8 South America Intravenous (IV) Ibuprofen by Country

    • 8.1 South America Intravenous (IV) Ibuprofen Sales, Revenue and Market Share by Country
      • 8.1.1 South America Intravenous (IV) Ibuprofen Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Intravenous (IV) Ibuprofen Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Intravenous (IV) Ibuprofen by Countries

    • 9.1 Middle East and Africa Intravenous (IV) Ibuprofen Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Intravenous (IV) Ibuprofen Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Intravenous (IV) Ibuprofen Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Intravenous (IV) Ibuprofen Sales and Growth Rate (2014-2019)

    10 Global Intravenous (IV) Ibuprofen Market Segment by Type

    • 10.1 Global Intravenous (IV) Ibuprofen Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Intravenous (IV) Ibuprofen Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Type (2014-2019)
    • 10.2 100 mg Dose Sales Growth and Price
      • 10.2.1 Global 100 mg Dose Sales Growth (2014-2019)
      • 10.2.2 Global 100 mg Dose Price (2014-2019)
    • 10.3 200 mg Dose Sales Growth and Price
      • 10.3.1 Global 200 mg Dose Sales Growth (2014-2019)
      • 10.3.2 Global 200 mg Dose Price (2014-2019)
    • 10.4 400 mg Dose Sales Growth and Price
      • 10.4.1 Global 400 mg Dose Sales Growth (2014-2019)
      • 10.4.2 Global 400 mg Dose Price (2014-2019)
    • 10.5 800 mg Dose Sales Growth and Price
      • 10.5.1 Global 800 mg Dose Sales Growth (2014-2019)
      • 10.5.2 Global 800 mg Dose Price (2014-2019)

    11 Global Intravenous (IV) Ibuprofen Market Segment by Application

    • 11.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2014-2019)
    • 11.2 Pain Sales Growth (2014-2019)
    • 11.3 Fever Sales Growth (2014-2019)
    • 11.4 Inflammation Sales Growth (2014-2019)

    12 Intravenous (IV) Ibuprofen Market Forecast (2019-2024)

    • 12.1 Global Intravenous (IV) Ibuprofen Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Intravenous (IV) Ibuprofen Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Intravenous (IV) Ibuprofen Market Forecast (2019-2024)
      • 12.2.2 Europe Intravenous (IV) Ibuprofen Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Intravenous (IV) Ibuprofen Market Forecast (2019-2024)
      • 12.2.4 South America Intravenous (IV) Ibuprofen Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Intravenous (IV) Ibuprofen Market Forecast (2019-2024)
    • 12.3 Intravenous (IV) Ibuprofen Market Forecast by Type (2019-2024)
      • 12.3.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Intravenous (IV) Ibuprofen Market Share Forecast by Type (2019-2024)
    • 12.4 Intravenous (IV) Ibuprofen Market Forecast by Application (2019-2024)
      • 12.4.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Intravenous (IV) Ibuprofen Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Intravenous (IV) Ibuprofen . Industry analysis & Market Report on Intravenous (IV) Ibuprofen is a syndicated market report, published as Global Intravenous (IV) Ibuprofen Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Intravenous (IV) Ibuprofen market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,804.88
      		4,207.32
      		5,609.76
      		3,264.24
      		4,896.36
      		6,528.48
      		537,694.80
      		806,542.20
      		1,075,389.60
      		290,406.00
      		435,609.00
      		580,812.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo